Brief: Marker Therapeutics Inc Filed 1-For-10 Reverse Stock Split
26/01/2023 23:29
Jan 26 (Reuters) - Marker Therapeutics Inc MRKR.O :
* MARKER THERAPEUTICS INC - FILED 1-FOR-10 REVERSE STOCK
SPLIT,
REDUCTION IN TOTAL NUMBER OF AUTHORIZED SHARES OF COMMON STOCK
TO 30 MILLION
* MARKER THERAPEUTICS INC - CO'S COMMON STOCK WILL BEGIN
TRADING
ON NASDAQ ON A SPLIT-ADJUSTED BASIS WHEN MARKET OPENS ON
THURSDAY, JAN 27
Further company coverage: MRKR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Marker Therapeutics
See all newsBrief: Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant To Advance MT-601 In Pancreatic Cancer
Marker Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Marker Therapeutics Inc expected to post a loss of 22 cents a share - Earnings Preview
Marker Therapeutics 2025 net loss widens, hurt by decline in grant income
Brief: Marker Therapeutics FY Basic EPS USD -0.79